Journal of the American Chemical Society · 2007 · 39 citations · 9 references
Life SciencesMedicinal ChemistryPharmacologyDrug DiscoveryEnzymologyStructure-activity RelationshipsAntibacterial PharmacologyAntibacterial TherapyAntibiotic ResistanceBeta-lactam ResistanceCarbapenem ResistanceEnzyme InhibitionActive Site Residue ConservationAmpc Beta-lactamasesBeta-lactamase InhibitorsCarbapenem AntibioticsCarbapenem-hydrolyzing EnzymesCarbapenemase EnzymesClass A Beta-lactamasesNucleophile Reactivity
O -Aryloxycarbonyl hydroxamates represent a new class of β-lactamase inhibitors. N -Benzyloxycarbonyl- O -(phenoxycarbonyl) hydroxylamine, for example, inactivates the class C Enterobacter cloacae P99 β-lactamase with a rate constant of 6.1 × 10 3 s -1 M -1; approximately two turnover events accompany the inhibition. N -Benzyloxycarbonyl- O -[(3-carboxyphenoxy)carbonyl] hydroxylamine is comparably effective. These compounds also inactivate the class A TEM β-lactamase. A crystal structure of the inactivated AmpC enzyme, another class C β-lactamase, reveals that the active site has become cross-linked by a carbamate bridge spanning Ser64, the active site nucleophile, and Lys315, a conserved active site residue.
9
Ken C. Usher, Larry C. Blaszczak, G. Scott Weston et al. · Biochemistry · 1998 · 116 citations
Roland P. A. Brown, Robin T. Aplin, Christopher J. Schofield · Biochemistry · 1996 · 110 citations
W. B. Renfrow, Charles R. Hauser · Journal of the American Chemical Society · 1937 · 63 citations